Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211M Sell
1,972,695
-286,289
-13% -$31.5M 0.31% 63
2026
Q1
$237M Sell
2,258,984
-679,726
-23% -$79.8M 0.4% 39
2025
Q4
$367M Buy
2,938,710
+298,453
+11% +$35.6M 0.62% 22
2025
Q3
$316M Buy
2,640,257
+9,694
+0.4% +$1.02M 0.57% 25
2025
Q2
$242M Sell
2,630,563
-690,707
-21% -$63M 0.5% 30
2025
Q1
$290M Sell
3,321,270
-258,758
-7% -$25.4M 0.7% 21
2024
Q4
$332M Sell
3,580,028
-1,185
-0% -$114K 0.86% 16
2024
Q3
$329M Sell
3,581,213
-106,276
-3% -$8.92M 0.85% 16
2024
Q2
$275M Sell
3,687,489
-2,161,187
-37% -$172M 0.76% 20
2024
Q1
$504M Sell
5,848,676
-730,645
-11% -$55.9M 1.66% 7
2023
Q4
$453M Buy
6,579,321
+1,290,275
+24% +$77.9M 1.63% 9
2023
Q3
$293M Buy
+5,289,046
New +$301M 1.23% 11

Other funds holding CRH

Aviva's CRH Position: Q2 2026 in Review

Aviva reduced its CRH (CRH) stake by 13% in Q2 2026, selling an estimated $31.5M and leaving 1,972,695 shares worth $211M. The position accounts for 0.31% of the portfolio, ranked #63.

Aviva first reported a position in CRH in Q3 2023 and has held it in 12 quarters since. The position peaked at $504M in Q1 2024. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Aviva held 1,972,695 shares of CRH worth $211M as of Q2 2026.
  • Aviva sold 286,289 CRH shares in Q2 2026, an estimated $31.5M.
  • CRH made up 0.31% of Aviva's portfolio in Q2 2026, its #63 holding.
  • Aviva first reported a position in CRH in Q3 2023 and has held it in 12 quarters since.
  • Aviva's CRH position peaked at $504M in Q1 2024.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.